| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| CONCIZUMAB | 1312299-39-0 | 68603V9EAF | 68603V9EAF | ALHEMO CONCIZUMAB CONCIZUMAB [INN] CONCIZUMAB [JAN] CONCIZUMAB [USAN] CONCIZUMAB [WHO-DD] CONCIZUMAB-MTCI IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TFPI (TISSUE FACTOR PATHWAY INHIBITOR, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR)), HUMANIZED MONOCLONAL ANTIBODY IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, TFPI))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*01 (86%) (IGHD)-IGHJ6*01 (93%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(229))) (122-448)) (135-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV2-29*02 (90%) IGKJ4*01)(11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (227-227'':230-230'')-BISDISULFIDE MAB2021 MAB-2021 NN7415 NN-7415 NNC-0172-0000-2021 NNC01722021 NNC0172-2021 NNC172-2021 |